Gemmus Pharma
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD18—27m (Dealroom.co estimates May 2014.)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$1.8m | Series A | ||
$3.3m | Series B | ||
Total Funding | CAD7.0m |
Related Content
Recent News about Gemmus Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.